Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Protein total increased? 90 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Protein total increased have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.

90
Reports of Protein total increased with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
7
Deaths
35
Hospitalizations

How Dangerous Is Protein total increased From ADALIMUMAB?

Of the 90 reports, 7 (7.8%) resulted in death, 35 (38.9%) required hospitalization, and 2 (2.2%) were considered life-threatening.

Is Protein total increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 90 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Protein total increased?

LENALIDOMIDE (360) EMTRICITABINE\TENOFOVIR DISOPROXIL (189) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (81) POMALIDOMIDE (67) TENOFOVIR DISOPROXIL (61) DEXAMETHASONE (41) LETROZOLE (41) CAPECITABINE (40) CLOZAPINE (40) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (40)

Which ADALIMUMAB Alternatives Have Lower Protein total increased Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Protein total increased Reports All Drugs Causing Protein total increased ADALIMUMAB Demographics